NNNNNNNNNNNNNNNN
SEAnews SEA Research, BLK 758 Yishun Street 72 #09-444 Singapore 760758
India Front Line Report
SEAnews Issue:monthly
tel:65-87221054
NNNNNNNNNNNNNNN
2013-08-16 ArtNo.44593
◆Editorial: Vaccinating policy
While the industry ministry is yet to come up with a final policy on whether foreign pharmaceuticals firms are to be allowed to buy existing pharmaceutical producers (brownfield acquisition, in jargon), the case for not doing so is getting weaker by the day—and, by continuing to defer the $1.6 billion takeover of Strides Arcolab’s injectables unit by the US Mylan, the FIPB is sending out the wrong signal to potential investors waiting to bring in money into the country.
When the debate first began some months ago, the industry ministry argued that allowing such takeovers would result in local production getting curtailed and prices of drugs rising.

【News source】


Editorial: Vaccinating policy


Your Comments


[Your Comments / Unsubscribe]/[您的意见/退订]/[ご意見/配信停止]
Please do not directly reply to the e-mail address which is used for delivering the newsletter.
请别用递送新闻的邮件地址而直接回信。
メールをお届けした送信専用アドレスには返信しないで下さい。
SEAnews 掲載記事の無断転載を禁じます。すべての内容は日本の著作権法並びに国際条約により保護されています。
Copyright 2003 SEAnews® All rights reserved. No reproduction or republication without written permission.